Trials / Unknown
UnknownNCT06062680
Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects
A Trial of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study used a single-center, randomized, open-label, three-period, crossover trial design. Fifteen healthy subjects were planned to be enrolled, and the subjects were randomly assigned to any group A, B and C in the order of screening, with 5 cases in each group
Conditions
- Adult Patients With Chronic Primary ITP
- Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Herombopag Olamine Tablets | Three Herombopag Olamine Tablets is administered to healthy subjects. |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2023-11-15
- Completion
- 2023-11-15
- First posted
- 2023-10-02
- Last updated
- 2023-10-02
Source: ClinicalTrials.gov record NCT06062680. Inclusion in this directory is not an endorsement.